3 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Palatin Technologies in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” Palatin Technologies stock.

Is PTN a buy Zacks?

The VGM Score are a complementary set of indicators to use alongside the Zacks Rank….Momentum Scorecard. More Info.

Zacks RankDefinitionAnnualized Return
1Strong Buy25.42%
2Buy19.05%
3Hold10.68%
4Sell6.41%

Who owns PTN stock?

Top 10 Owners of Palatin Technologies Inc

StockholderStakeShares owned
The Vanguard Group, Inc.4.07%9,415,677
BlackRock Fund Advisors1.35%3,131,704
Geode Capital Management LLC0.71%1,651,856
Acadian Asset Management LLC0.40%925,823

What does Palatin Tech do?

Palatin Technologies, Inc. is a biopharmaceutical company. The Company researches products for the treatment of male and female sexual dysfunction, congestive heart failure, obesity, and cachexia.

Who is buying Palatin Technologies Inc (PTN) stock?

The Executive VP and CFO of Palatin Technologies Inc (PTN) is Buying Shares. Yesterday, the Executive VP and CFO of Palatin Technologies Inc (PTN), Stephen Wills, bought shares of PTN for $43K.

What does PTN stand for?

Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2019 Results Teleconference and Webcast to be held on September 12, 2019 CRANBURY, N.J. , Sept. 12, 2019 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing

When will Palatin Technologies release its 2021 third quarter earnings?

NEW YORK, NY / ACCESSWIRE / May 17, 2021 / Palatin Technologies, Inc. (NYSE:PTN) will be discussing their earnings results in their 2021 Third Quarter Earnings call to be held on May 17, 2021 at 11:00 AM Eastern Time.